+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Peptide Antibiotics Market by Product (Bacitracin, Colistin, Daptomycin), Route Of Administration (Intramuscular, Intravenous, Oral), Formulation, Source, Application, End Use, Distribution Channel - Global Forecast 2025-2030- Product Image
Peptide Antibiotics Market by Product (Bacitracin, Colistin, Daptomycin), Route Of Administration (Intramuscular, Intravenous, Oral), Formulation, Source, Application, End Use, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Peptide Antibiotics Market by Product (Bacitracin, Colistin, Daptomycin), Route Of Administration (Intramuscular, Intravenous, Oral), Formulation, Source, Application, End Use, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666281
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Peptide antibiotics are gaining strategic relevance as advanced solutions for combating antimicrobial resistance across global healthcare and allied sectors. Their unique mechanisms, biotechnological innovation, and evolving clinical utility command growing attention from healthcare leaders, pharmaceutical manufacturers, and policymakers seeking versatile, resilient alternatives to standard antibiotics.

Market Snapshot: Peptide Antibiotics Market Growth and Opportunity

The peptide antibiotics market grew from USD 5.58 billion in 2024 to USD 6.15 billion in 2025. It is expected to continue growing at a CAGR of 9.84%, reaching USD 9.81 billion by 2030. Senior leaders in pharmaceutical, biotechnology, and clinical research sectors are monitoring this market’s impressive expansion, spurred by urgent clinical demand for new antimicrobial classes, regulatory shifts, and enhanced product pipelines. Innovations driving the peptide antibiotics market include developed analogues with improved potency, broader therapeutic application, and better delivery options especially as alternatives to traditional antimicrobials are prioritized.

Scope & Segmentation

  • Product Types: Bacitracin, Colistin, Daptomycin, Polymyxin B
  • Routes of Administration: Intramuscular, Intravenous, Oral, Topical
  • Formulations: Lyophilized powder, Solution, Powder, Cream, Ointment
  • Source: Natural derivatives, Synthetic analogues
  • Applications: Clinical use, Food preservation, Veterinary use
  • End-Users: Clinics, Hospitals, Veterinary clinics
  • Distribution Channels: Hospital pharmacy, Online pharmacy, Retail pharmacy
  • Regions Covered: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East, Africa (covering United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Major Players: Merck & Co., Inc., Pfizer Inc., Astellas Pharma Inc., F. Hoffmann-La Roche Ltd., Sanofi S.A., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Fresenius Kabi AG, Hikma Pharmaceuticals PLC

Key Takeaways for Senior Decision-Makers

  • Biotechnological advances are rapidly expanding the pipeline of peptide antibiotics and enabling more robust responses to antimicrobial resistance.
  • Strategic collaborations—linking biotech, contract research organizations, and clinical institutions—increasingly drive discovery and early-stage development.
  • Diversification of formulations and delivery routes supports broader use cases, easing adaptation in both inpatient and outpatient scenarios, as well as in animal health and food sectors.
  • Regional partnerships in Asia-Pacific and Americas leverage established infrastructure and government incentives to scale manufacturing and accelerate new launches.
  • Regulatory frameworks are evolving, allowing greater flexibility in trial designs and product approvals and enabling faster market entry for novel compounds.
  • Integrated innovation across medicinal chemistry, process engineering, and computational methods supports value creation and sustained differentiation in highly competitive markets.

Tariff Impact on Peptide Antibiotics Supply Chains

Recent changes in United States tariff structures are affecting peptide antibiotics supply chains. Manufacturers are facing increased duties on imported raw materials such as specialized amino acids, leading to production cost pressures. This is prompting strategic evaluations of sourcing, including the establishment of regional production hubs and adoption of more vertically integrated operations. Companies must adapt by optimizing procurement, inventory planning, and contract strategies to maintain supply resilience and cost efficiency in a shifting global trade environment.

Methodology & Data Sources

This analysis draws on a robust mix of qualitative expert interviews, peer-reviewed literature, patent disclosures, and proprietary databases specific to peptide antibiotics. The data set is strengthened by scenario planning, supply chain mapping, and iterative review sessions with industry thought leaders to validate trends and strategic implications.

Why This Report Matters

  • Enables strategic planning for pharmaceutical executives seeking sustainable growth in the peptide antibiotics market.
  • Provides actionable insights into technology trends, regulatory pathways, and regional growth drivers affecting investment and operational decisions.
  • Helps leaders identify and mitigate risks related to supply chain dynamics, cost structures, and evolving trade policies in this segment.

Conclusion

Peptide antibiotics are positioned to address unmet medical and industrial needs through targeted innovation and adaptive strategies. Senior executives can leverage this report to anticipate market shifts and inform strategic decisions in a complex, evolving landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increased investment in synthetic peptide optimization to combat multidrug resistant bacterial strains
5.2. Rising adoption of oral peptide antibiotic formulations for improved patient compliance
5.3. Implementation of AI-driven peptide design platforms for accelerated drug discovery
5.4. Strategic partnerships between biotech firms and academic institutions to enhance peptide antibiotic pipelines
5.5. Regulatory approvals of novel cyclic peptide antibiotics for hospital-acquired infection treatment
5.6. Emerging use of nanocarrier delivery systems to enhance peptide antibiotic stability and bioavailability
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Peptide Antibiotics Market, by Product
8.1. Introduction
8.2. Bacitracin
8.3. Colistin
8.4. Daptomycin
8.5. Polymyxin B
9. Peptide Antibiotics Market, by Route Of Administration
9.1. Introduction
9.2. Intramuscular
9.3. Intravenous
9.4. Oral
9.5. Topical
10. Peptide Antibiotics Market, by Formulation
10.1. Introduction
10.2. Injectable
10.2.1. Lyophilized Powder
10.2.2. Solution
10.3. Powder
10.4. Topical Formulation
10.4.1. Cream
10.4.2. Ointment
11. Peptide Antibiotics Market, by Source
11.1. Introduction
11.2. Natural
11.3. Synthetic
12. Peptide Antibiotics Market, by Application
12.1. Introduction
12.2. Clinical Use
12.3. Food Preservation
12.4. Veterinary Use
13. Peptide Antibiotics Market, by End Use
13.1. Introduction
13.2. Clinics
13.3. Hospitals
13.4. Veterinary Clinics
14. Peptide Antibiotics Market, by Distribution Channel
14.1. Introduction
14.2. Hospital Pharmacy
14.3. Online Pharmacy
14.4. Retail Pharmacy
15. Americas Peptide Antibiotics Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Peptide Antibiotics Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Peptide Antibiotics Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Merck & Co., Inc.
18.3.2. Pfizer Inc.
18.3.3. Astellas Pharma Inc.
18.3.4. F. Hoffmann-La Roche Ltd.
18.3.5. Sanofi S.A.
18.3.6. GlaxoSmithKline plc
18.3.7. Teva Pharmaceutical Industries Ltd.
18.3.8. Sandoz International GmbH
18.3.9. Fresenius Kabi AG
18.3.10. Hikma Pharmaceuticals PLC
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. PEPTIDE ANTIBIOTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. PEPTIDE ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. PEPTIDE ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. PEPTIDE ANTIBIOTICS MARKET: RESEARCHAI
FIGURE 30. PEPTIDE ANTIBIOTICS MARKET: RESEARCHSTATISTICS
FIGURE 31. PEPTIDE ANTIBIOTICS MARKET: RESEARCHCONTACTS
FIGURE 32. PEPTIDE ANTIBIOTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PEPTIDE ANTIBIOTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY BACITRACIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY BACITRACIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY COLISTIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY COLISTIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DAPTOMYCIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DAPTOMYCIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY POLYMYXIN B, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY POLYMYXIN B, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY OINTMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY OINTMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY NATURAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY NATURAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SYNTHETIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICAL USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY FOOD PRESERVATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY FOOD PRESERVATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PEPTIDE ANTIBIOTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 119. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 120. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 121. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 124. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 125. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 126. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 127. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2024 (USD MILLION)
TABLE 128. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2025-2030 (USD MILLION)
TABLE 129. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 130. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 131. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 134. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 135. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. CANADA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 138. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 139. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 140. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 141. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 142. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 143. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 144. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 145. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2024 (USD MILLION)
TABLE 146. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2025-2030 (USD MILLION)
TABLE 147. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 152. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 153. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. MEXICO PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA PEPTIDE ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 230. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 231. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 232. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 233. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 234. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 235. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 236. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 237. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2024 (USD MILLION)
TABLE 238. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2025-2030 (USD MILLION)
TABLE 239. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 240. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 241. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 244. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 245. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. GERMANY PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 248. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 249. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 252. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 253. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 254. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 255. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2024 (USD MILLION)
TABLE 256. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2025-2030 (USD MILLION)
TABLE 257. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 258. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 259. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 262. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 263. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. FRANCE PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 284. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 285. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 286. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 287. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 288. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 289. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 290. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 291. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2024 (USD MILLION)
TABLE 292. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2025-2030 (USD MILLION)
TABLE 293. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 294. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 295. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 298. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 299. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. ITALY PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 302. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 303. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 304. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 305. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 306. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 307. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 308. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 309. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2024 (USD MILLION)
TABLE 310. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2025-2030 (USD MILLION)
TABLE 311. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 312. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 313. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 314. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 315. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 316. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 317. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. SPAIN PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2018-2024 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY TOPICAL FORMULATION, 2025-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 330. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 331. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 332. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 333. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 334. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 335. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 336. UNITED ARAB EMIRATES PEPTIDE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 337. SAUDI ARABIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 338. SAUDI ARABIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 339. SAUDI ARABIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 340. SAUDI ARABIA PEPTIDE ANTIBIOTICS MARKET SIZE, BY ROUTE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Peptide Antibiotics market report include:
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Astellas Pharma Inc.
  • F. Hoffmann-La Roche Ltd.
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Fresenius Kabi AG
  • Hikma Pharmaceuticals PLC

Table Information

Report AttributeDetails
No. of Pages193
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.15 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.81 Billion
Compound Annual Growth Rate9.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Peptide Antibiotics Market Size, Share & Trends Analysis Report By Disease (Skin Infection, HABP/VABP), By Route of Administration (Injectable, Oral), By Product, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Peptide Antibiotics Market Size, Share & Trends Analysis Report By Disease (Skin Infection, HABP/VABP), By Route of Administration (Injectable, Oral), By Product, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Peptide Antibiotics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Peptide Antibiotics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Peptide Antibiotics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Peptide Antibiotics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 130 Pages
  • Global
From
Peptide Antibiotics - Global Strategic Business Report - Product Image

Peptide Antibiotics - Global Strategic Business Report

  • Report
  • 381 Pages
  • Global
From
Peptide Antibiotics Market Report 2025 - Product Image

Peptide Antibiotics Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Peptide Antibiotics Market

Peptide antibiotics are a type of antibiotic derived from peptides, which are short chains of amino acids. They are used to treat a variety of bacterial infections, including those caused by Gram-positive and Gram-negative bacteria. Peptide antibiotics are generally more effective than traditional antibiotics, as they are able to target specific bacterial cells and are less likely to cause resistance. They are also less likely to cause side effects, such as nausea and vomiting. Peptide antibiotics are typically administered intravenously or intramuscularly, and can be used in combination with other antibiotics. The peptide antibiotics market is growing rapidly, driven by the increasing prevalence of antibiotic-resistant bacteria and the need for more effective treatments. The market is expected to continue to grow in the coming years, as more research is conducted into the development of new peptide antibiotics. Some companies in the peptide antibiotics market include Merck, Pfizer, GlaxoSmithKline, Sanofi, and AstraZeneca. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.